Re: KC--Fellow patient has aspergillus growing in the brain

[Guest guest]

,

Yes she has had scans done on her sinuses and she has never had a

sinus infection. All clear.

KC

Sunday, January 14, 2007Costs to mend

> > > courthouse cause concernChattanooga Times Free Press Sat, 13

Jan

> > > 2007 10:10 PM PSTMoney spent on new air conditioning, work to

> rid

> > > mold questionedBy Ian Berry Staff Writer With at least $6.2

> > million

> > > spent on renovations to the Hamilton County Courthouse since

> > 2001,

> > > the county continues to fight mold infiltrating the historic

> > > building.The renovations, records show, have included more

than

> > > $500,000 to waterproof a leaky foundation thought to be the

> cause

> > of

> > > the building's continuing mold problems. Despite that

foundation

> > > work, moisture and mold persist on the first floor, where

> > offices,

> > > hallways and the entrance onto Walnut Street have been

inspected

> > and

> > > cleaned of mold in recent weeks. " Throwing good money after

bad "

> > is

> > > how some Hamilton County officials recently have described

> > expenses

> > > for some of the county's older buildings, including the

> > > courthouse.One of those officials, County Commissioner Fred

> > > Skillern, said he supported the latest courthouse work, but

may

> > have

> > > felt differently " if I knew then what I knew now. " The

> courthouse

> > > renovations are " almost a nightmare, " Commission Chairman

Larry

> > > Henry said.NO TURNING BACK Built in 1912, the courthouse is

in

> > the

> > > midst of " Phase V " renovations intended in part to address

mold

> > > problems in several locations, including offices for the

county

> > > clerk, register of deeds and clerk and master.In addition to

the

> > > $6.2 million approved since 2001, the county included $3

million

> > for

> > > further renovations in the $125 million bond issue approved

last

> > > year.There also have been continuing mold problems on the

third

> > > floor, where Clerk and Master Lee Akers, the only official to

> > > complain publicly about the mold, has set up portable air

> > purifiers.

> > > Mr. Akers said he wonders if mold is to blame for his chronic

> > > obstructive pulmonary disease, or his employees' frequent

bouts

> > of

> > > pneumonia.While acknowledging the problems, commissioners

also

> > say

> > > that at this point there's no turning back. " From a cost-

> > > effectiveness standpoint, you really should tear it down and

> > start

> > > over, " Commissioner Casavant said. " (But) we've put a

> lot

> > of

> > > money into the courthouse during the past 10 years. " County

Mayor

> > > Claude Ramsey said a new courthouse would cost " many times

what

> > > we've spent on this beautiful facility, which is a great

asset

> to

> > > the community. " The city is in the midst of a $12 million

> > renovation

> > > to its City Hall. FROM THE GROUND UP Mr. Ramsey said the

first

> > phase

> > > of the renovations to address the courthouse foundation was

> > intended

> > > to stop moisture. The plan all along, he said, was to bring

the

> > > building up to standard and then address the areas of

mold. " It

> > > certainly helped a great deal, " he said of the foundation

> > work.The

> > > health and well-being of county employees is his top concern,

> Mr.

> > > Ramsey said. He noted his office has had virtually no

> renovations

> > > since he took office in 1994. " I work here every day, " Mr.

> Ramsey

> > > said.Even if the county had been inclined to build a new

> > facility,

> > > finding a location would have been a problem.Curtis

said

> if

> > > the county could have looked into " a crystal ball " 10 years

ago,

> > it

> > > would have looked at building a new joint city-county

facility,

> > > similar to what exists in Knoxville. A potential location

could

> > have

> > > been where the new County Election Commission Building opened

on

> > > Amnicola Highway. " It's too late for that, " Mr.

said.BEYOND

> > THE

> > > COURTHOUSE Both Dr. Casavant and Mr. Skillern said the county

> > should

> > > think about a building program to replace some of the other

old

> > > county facilities.Earlier this month, Dr. Casavant asked

county

> > > officials to conduct an audit of all the county's facilities.

He

> > > said he was taken aback to learn that an entire floor of the

> > > Hamilton County-Chattanooga Courts Building was being used

for

> > > parking, and he said the cost of a new heating, ventilation

and

> > air

> > > conditioning system at the Newell Tower on East Seventh

Street,

> > > which houses other county offices, also raised questions.That

> > > building's HVAC system will cost more than $700,000. The

county

> > > received only one bid on the project, after three attempts to

> > > solicit bids.Dr. Casavant pointed out that, unlike the

> > courthouse,

> > > Newell Tower is not historic. " At what point do you decide it

> > would

> > > be better to issue some bonds and build a new building and

have

> > it

> > > pay off? " he said.County Finance Director Louis

> > acknowledged

> > > the concern but said all of the offices in Newell Tower, for

> > > instance, need to be downtown. " We frankly right now don't

have

> > > another location to put a building such as this, " Mr.

> > > said. " We've proven that new buildings are most cost-

efficient

> > than

> > > older buildings, but quite frankly that's how we've acquired

> > > additional space in the downtown campus, by purchasing old

> > > buildings. " Mr. Ramsey has in response to Dr. Casavant's

request

> > > appointed a three-person committee to take an inventory of

all

> > > county buildings including the county's maintenance director,

> > > engineer and real property manager.He said taking inventory

of

> > the

> > > buildings will be helpful, although any new county buildings

> > would

> > > be far in the future. " We're building schools right now, " Mr.

> > Ramsey

> > > said. " Somewhere there ought to be a longrange plan. But as

of

> > now,

> > > we continue to concentrate on the school building program

under

> > > way. " E-mail Ian Berry at iberry@ RENOVATION OUTLAYS The

Hamilton

> > > County Commission has approved the following expenditures to

> > > renovate these buildings since 2000: Hamilton County

Courthouse —

>

> > > $6.2 million Heating/ventilation/ air conditioning repairs —

> > $1.53

> > > million Hamilton County Justice Building (includes jail) —

$1.5

> > > million Newell Towers — $903,984 MLK Building — 209,000

Mayfield

> > > Annex — 193,872 Hamilton County-Chattanooga Courts Building:

> > > $159,884 Source: Hamilton County documents -------------------

---

> -

> > ---

> > > -------Need Mail bonding?Go to the Q & A for great

> tips

> > > from Answers users.[Non-text portions of this message

> have

> > > been removed]

> > > >

> > > >

> > > > __________________________________________________________

> > > > Get into the holiday spirit, chat with Santa on Messenger.

> > > > http://imagine-

windowslive.com/minisites/santabot/default.aspx?

> > > locale=en-us

> > > >

> > > >

[Guest guest]

, I get frequent migraines but no sinus " effects " , unless an

allergen triggers. Did you have sinus trouble ALSO, as well as

migraines so that the sinus infection was no surprise to you?

--- In , " ldelp84227 " <ldelp84227@...>

wrote:

>

> KC when you talk about Sharon's head pain has she had cat scans of

> the sinuses, etc. I have migranes many times but when I first got

> ill I had such severe pain and had been on alot of meds and I >

[Guest guest]

LS,

Thanks, I appreciate the suggestion. We know that the pain was

caused by her exposure, in a 9 yr period she was without headpain a

total of 2 weeks. Other than that it has been constant. The pain is

NOT VASCULAR in nature, it is a direct result of the sheathing

around the nerves being damaged. It's like a wire being stripped of

its coating, the electric current goes all over, instead of

following a direct path. The facial pain/numbness is damage done to

the trigeminal nerve. She has been on many antiseizure medications

for what the doctors thought were vascular migranes, they did not

touch the pain, because and I will repeat myself, they are not

vascular.

No she is not being re-exposed, these pains are unfortunately one of

the symptoms that continue to remain since her exposure at work. The

only time they will disappear is when she takes a strong " hit " and

goes into a strokelike episode. As soon as that passes the pain

comes back and remains.. I've had Dr.Lipsey test our home and it is

safe. We also know this because she would be in worse condition if

it was not a " clean " environment, not to mention we have had

several " moldies " here and they did not have any reactions or

symptoms.

KC

--- In , LiveSimply <quackadillian@...>

wrote:

>

> ,

>

> Here is some data from PubMed about a closely related drug (to

piracetam) -

> levetiracetam

>

> Piracetam is now 'in the public domain' so it's cheap and

unprofitable. It

> isn't patentable.

> So no research gets done on it anymore, unless the researcher

doesn't care

> about money.. (almost unheard of)

>

> It's a complex picture.. But as I said, it helped me when I was

living in

> stachy hell, a LOT...

>

> Clin Ter. 2004 Feb-Mar;155(2-3):79-87. Compound via

> MeSH,<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

itool=pubmed_AbstractPlus & db=pubmed & cmd=Display & dopt=pubmed_pccompoun

d_mesh & from_uid=15244112>

> Substance

> via MeSH,<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

itool=pubmed_AbstractPlus & db=pubmed & cmd=Display & dopt=pubmed_pcsubstan

ce_mesh & from_uid=15244112>

> LinkOut<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

itool=pubmed_AbstractPlus & cmd=Retrieve & db=pubmed & %

20list_uids=15244112 & dopt=ExternalLink>

> Antiepileptic drugs in migraine prophylaxis: state of the art.

>

> - *Capuano A*<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

db=pubmed & cmd=Search & itool=pubmed_AbstractPlus & term=%22Capuano+A%22%

5BAuthor%5D>,

>

> - *Vollono C*<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

db=pubmed & cmd=Search & itool=pubmed_AbstractPlus & term=%22Vollono+C%22%

5BAuthor%5D>,

>

> - *Mei D*<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

db=pubmed & cmd=Search & itool=pubmed_AbstractPlus & term=%22Mei+D%22%

5BAuthor%5D>,

>

> - *Pierguidi

> L*<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

db=pubmed & cmd=Search & itool=pubmed_AbstractPlus & term=%22Pierguidi+L%

22%5BAuthor%5D>,

>

> - *Ferraro D*<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

db=pubmed & cmd=Search & itool=pubmed_AbstractPlus & term=%22Ferraro+D%22%

5BAuthor%5D>,

>

> - *Di Trapani

> G*<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

db=pubmed & cmd=Search & itool=pubmed_AbstractPlus & term=%22Di+Trapani+G%

22%5BAuthor%5D>

> .

>

> Neurology Institute, Headache Center, Universita Cattolica Sacro

Cuore Roma,

> Italia.

>

> Antiepileptic drugs have proven their efficacy in the prophylactic

treatment

> of migraine. Our study comprises a clinical trial that examines

the efficacy

> of gabapentin and topiramate and a description of the pharmacologic

> characteristics and the efficacy of tiagabine, lamotrigine,

levetiracetam

> and zonisamide. Antiepileptic drugs have multiple modes of action

which can

> explain their efficacy in reducing neuronal excitability which is

proven in

> epilepsy and postulated in migraine. The relationship between

epilepsy and

> migraine has, in fact, been much debated but never convincingly

proven.

> Antiepileptic drugs could be useful in migraine prophylaxis as

some of these

> have determined a reduction in the monthly frequency and intensity

of crises

> in subjects suffering from migraine with and without aura. These

are the

> aims that have been proposed by the U.S. Headache Consortium

Evidence-Based

> Guidelines. Further double-blind placebo-controlled studies are

necessary in

> order to assess their safety and efficacy.

>

> PMID: 15244112 [PubMed - indexed for MEDLINE]

>

> Headache. 2004 Mar;44(3):238-43.[image: Click here to

> read]<http://www.ncbi.nlm.nih.gov/entrez/utils/fref.fcgi?

itool=AbstractPlus-

def & PrId=3046 & uid=15012661 & db=PubMed & url=http://www.blackwell-

synergy.com/openurl?genre=article & sid=nlm:pubmed & issn=0017-

8748 & date=2004 & volume=44 & issue=3 & spage=238>

> Compound via MeSH,<http://www.ncbi.nlm.nih.gov/entre%

20z/query.fcgi?

itool=pubmed_AbstractPlus & db=pubmed & cmd=Display & dopt=pubmed_pccompoun

d_mesh & from_uid=15012661>

> Substance

> via MeSH,<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

itool=pubmed_AbstractPlus & db=pubmed & cmd=Display & dopt=pubmed_pcsubstan

ce_mesh & from_uid=15012661>

> LinkOut<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

itool=pubmed_AbstractPlus & cmd=Retrieve & db=pubmed & list_uids=15012661 & d

opt=ExternalLink>

> Efficacy and safety of levetiracetam in pediatric migraine.

>

> - * GS*<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

db=pubmed & cmd=Search & itool=pubmed_AbstractPlus & term=%22+GS%22%

5BAuthor%5D>

> .

>

> Pediatric Neurology Department, Hillcrest Healthcare System,

Children's

> Medical Center, Tulsa, Okla. 74104, USA.

>

> BACKGROUND: Headache is a frequent occurrence among children and

> adolescents. Chronic headaches can be severe and disabling, and

require

> prophylactic treatment; however, additional data on the use of

prophylactic

> medications for migraine in children are needed. OBJECTIVE: To

review the

> efficacy and safety of levetiracetam (Keppra) in pediatric

patients with a

> history of recurrent headache. DESIGN/METHODS: Data from 19

pediatric

> patients were retrospectively reviewed. The initial dose of

levetiracetam

> was usually 125 or 250 mg twice daily, but varied depending upon

clinical

> judgment. RESULTS: Charts of 9 girls and 10 boys (mean age, 11.9

years) were

> reviewed. A variety of medications, including triptans, had been

used before

> initiating treatment with levetiracetam. Mean headache frequency

before

> treatment was 6.3 per month (standard deviation [sD], 3.8;

confidence

> interval [CI], 4.4 to 8.1). Duration of headaches ranged from 0.25

to 8

> years. Migraine (63.2%) and migraine with aura (15.8%) were the

most common

> types of headache reported. Most patients (89.5%) had headaches

that were

> severe. After treatment, the mean headache frequency decreased to

1.7 per

> month (SD, 2.7; CI, 0.4 to 3.0), representing a reduction compared

with

> baseline (P <.0001). Levetiracetam eliminated headaches in 10

patients (

> 52.6%), and 7 patients (36.8%) had less severe and less frequent

headaches.

> Levetiracetam did not have an effect on headaches in 2 patients

(10.5%).

> Mean duration of treatment with levetiracetam was 4.1 months.

Doses ranged

> from 125 to 750 mg twice daily. Sixteen patients (84.2%) reported

no side

> effects on levetiracetam. One patient experienced

asthenia/somnolence and

> dizziness, and irritable, hyperactive, and hostile behavior led to

> discontinuation of levetiracetam in another patient. A third

patient

> experienced irritability and moodiness that attenuated after 1

month of

> treatment and did not require discontinuation. CONCLUSIONS: In

this small

> retrospective review, levetiracetam was found to be generally well

tolerated

> and appears to be a promising candidate for additional evaluation

in

> well-controlled clinical trials of pediatric patients with

migraine.

>

> PMID: 15012661 [PubMed - indexed for MEDLINE]

>

> Epilepsy Res. 2003 Oct;56(2-3):135-45.[image: Click here to

> read]<http://www.ncbi.nlm.nih.gov/entrez/utils/fref.fcgi?

itool=AbstractPlus-

def & PrId=3048 & uid=14642998 & db=PubMed & url=http://linkinghub.elsevier.c

om/retrieve/pii/S092012110300158X>

> Compound via MeSH,<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

itool=pubmed_AbstractPlus & db=pubmed & cmd=Display & dopt=pubmed_pccompoun

d%20_mesh & from_uid=14642998>

> Substance

> via MeSH,<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

itool=pubmed_AbstractPlus & db=pubmed & cmd=Display & dopt=pubmed_pcsubstan

ce_mesh & from_uid=14642998>

> LinkOut<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

itool=pubmed_AbstractPlus & cmd=Retrieve & db=pubmed & list_uids=14642998 & d

opt=ExternalLink>

> Tolerability of levetiracetam in elderly patients with CNS

disorders.

>

> - *Cramer JA*<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

db=pubmed & cmd=Search & itool=pubmed_AbstractPlus & term=%22Cramer+JA%22%

5BAuthor%5D>,

>

> - *Leppik IE*<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

db=pubmed & cmd=Search & itool=pubmed_AbstractPlus & term=%22Leppik+IE%22%

5BAuthor%5D>,

>

> - *Rue KD*<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

db=pubmed & cmd=Search & itool=pubmed_AbstractPlus & term=%22Rue+KD%22%

5BAuthor%5D>,

>

> - *Edrich P*<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

db=pubmed & cmd=Search & itool=pubmed_AbstractPlus & term=%22Edrich+P%22%

5BAuthor%5D>,

>

> - *Kramer G*<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

db=pubmed & cmd=Search & itool=pubmed_AbstractPlus & term=%22Kramer+G%22%

5BAuthor%5D>

> .

>

> Department of Psychiatry, Yale University School of Medicine, 950

> Avenue (G7E, Room 7-127), West Haven, CT 06516-2770, USA.

> Joyce.Cramer@...

>

> The purpose of this analysis was to compare treatment-emergent

adverse

> events (TEAE) related to use of levetiracetam (LEV) reported by

young and

> elderly patients with anxiety and cognitive disorders, and young

epilepsy

> patients. The LEV database includes reports of TEAE from trials of

patients

> with diagnoses of a cognitive disorder (N=719), an anxiety disorder

> (N=1510), or localization-related epilepsy (N=1023) who

participated in

> clinical trials lasting up to 16 weeks. Patients were grouped as

young (<65

> years) or elderly (> or = 65 years). The most common TEAE

occurring most

> frequently in the LEV-treated groups were abdominal pain, asthenia,

> headache, anorexia, weight loss, dizziness, insomnia, somnolence,

and

> tremor. The only significant differences in TEAE were seen between

young and

> elderly groups with anxiety disorders (>3% higher for LEV than for

> placebo-treated patients) in headache (5.2% elderly, -0.9% young,

P=0.041),

> and tremor (5.2 and -0.5%, respectively, P=0.022) and between

young anxiety

> patients and young epilepsy patients for somnolence (-0.7 and 5.4%,

> respectively, P=0.036). For the other TEAEs there was no evidence

for

> consistent differences between young and elderly patients and

between

> patients with different CNS disorders. Overall, LEV was well

tolerated by

> all patient groups. The favorable adverse event profile suggests

that LEV

> might be suitable for use by elderly patients.

>

> PMID: 14642998 [PubMed - indexed for MEDLINE]

> Eur Arch Otorhinolaryngol. 1997;254 Suppl 1:S55-7. Compound via

> MeSH,<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

itool=pubmed_AbstractPlus & db=pubmed & cmd=Display & dopt=pubmed_pccompoun

d_mesh & from_uid=9065628>

> Substance

> via MeSH,<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

itool=pubmed_AbstractPlus & db=pubmed & cmd=Display & do%

20pt=pubmed_pcsubstance_mesh & from_uid=9065628>

> LinkOut<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

itool=pubmed_AbstractPlus & cmd=Retrieve & db=pubmed & list_uids=9065628 & do

pt=ExternalLink>

> Vestibular disorders in patients with migraine.

>

> - *Szirmai A*<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

db=pubmed & cmd=Search & itool=pubmed_AbstractPlus & term=%22Szirmai+A%22%

5BAuthor%5D>

> .

>

> Department of Oto-Rhino-Laryngology, Head and Neck Surgery,

Semmelweis

> University Medical School, Budapest, Hungary.

>

> Vestibular symptoms frequently occur in patients with migraine

headache. The

> common migraine is defined in neurology as a unilateral, pulsating

headache,

> which may be associated with nausea and vomiting, and lasts one or

several

> days. In the classic form patients have visual prodromal symptoms.

Focal

> neurological signs in the migraine complique include, for example,

> oculomotor palsy and vestibular abnormalities. This so-called

vestibular

> migraine is different from basilar migraine, which involves the

irritation

> of the cervical sympathetic system, and can cause symptoms that

resemble

> transient brainstem ischemia. In order to evaluate vestibular

dysfunction

> electronystagmography (ENG) was used. Patients frequently had

abnormal

> caloric test responses, especially with a directional

preponderance, and

> most had a spontaneous nystagmus. In the migraine attack the

patients are

> presumed to have hypersensitivity of the labyrinth with nausea and

vomiting,

> while in the headache-free period the ENG was almost normal. At

present, we

> have had a high success rate in treating patients with pyracetam.

epam

> was used to treat basilar migraine and flunarizine to prevent

vestibular

> migraine.

>

> PMID: 9065628 [PubMed - indexed for MEDLINE]

> Vrach Delo. 1990 Apr;(4):71-3. Compound via

> MeSH,<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

itool=pubmed_AbstractPlus & db=pubmed & cmd=Display & dopt=pubmed_pccompoun

d_mesh & from_uid=2275176>

> Substance

> via MeSH,<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

itool=pubmed_AbstractPlus & db=pubmed & cmd=Display & dopt=pubmed_pcsubstan

ce_mesh & from_uid=2275176>

> LinkOut<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

itool=pubmed_AbstractPlus & cmd=Retrieve & db=pubmed & list_uids=2275176 & %

20;dopt=ExternalLink>

> [The elimination of chemotherapy side effects in pulmonary

tuberculosis

> patients] [Article in Russian]

>

> - *Bal'tseva

> LB*<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

db=pubmed & cmd=Search & itool=pubmed_AbstractPlus & term=%22Bal%

27tseva+LB%22%5BAuthor%5D>,

>

> - *Mel'nik GV*<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

db=pubmed & cmd=Search & itool=pubmed_AbstractPlus & term=%22Mel%27nik+GV%

22%5BAuthor%5D>,

>

> - *Man'ko VP*<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

db=pubmed & cmd=Search & itool=pubmed_AbstractPlus & term=%22Man%27ko+VP%

22%5BAuthor%5D>

> .

>

> Neurotoxic side-effects of tuberculosis chemotherapy occurred in

14.9% of

> patients with tuberculosis treated prophylactically with

intramuscular

> pyridoxine infusions. Use of small doses of nootropil (piracetam)

allowed to

> control the side-effects (headache and vertigo, sleep disorders,

irritation,

> memory disorders) and to continue treatment with isoniazide, one

of the most

> potent tuberculostatic agents.

>

> PMID: 2275176 [PubMed - indexed for MEDLINE]

>

> [Piracetam and the indicators of cerebral hemodynamics, lipid

metabolism and

> rheological properties of blood in the initial forms of

cerebrovascular

> disorders] [Article in Russian]

>

> - *Eninia GI*<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

db=pubmed & cmd=Search & itool=pubmed_AbstractPlus & term=%22Eninia+GI%22%

5BAuthor%5D>,

>

> - *Timofeeva

> TN*<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

db=pubmed & cmd=Search & itool=pubmed_AbstractPlus & term=%22Timofeeva+TN%

22%5BAuthor%5D>

> .

>

> Piracetam was applied to the treatment of 60 patients with the

initial

> manifestations of brain blood supply failure and stage I

encephalopathy

> associated with circulatory disorders. Echopulsography of the

intracranial

> vessels and dopplerography of the extracranial vessels of the

brain were

> employed, changes in lipid metabolism, rheological and coagulation

> properties of the blood were defined. Continuous use of piracetam

per os was

> found to produce a number of beneficial therapeutic effects. Some

patients

> suffering from encephalopathy associated with circulatory

disorders showed

> headache enhancement after intake of 1.6 g of the drug,

accompanied by a

> considerable increase of the amplitude of pulse fluctuations,

prompting the

> reduction of the drug dose. Piracetam decreased the high vascular

resistance

> and raised the lowered volume of pulse fluctuations. In all the

patients

> examined, aggregation of formed elements of the blood returned to

normal

> whereas the content of atherogenic lipids in blood serum

significantly

> dropped.

>

> PMID: 1963971 [PubMed - indexed for MEDLINE]

> Zh Nevropatol Psikhiatr Im S S Korsakova. <javascript:AL_get

(this, 'jour',

> 'Zh Nevropatol Psikhiatr Im S S Korsakova.');> 1989;89(12):19-23.

Related

> Articles,<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

itool=pubmed_Abstract & db=pubmed & cmd=Display & dopt=pubmed_pubmed & from_u

id=2699140 & itool=ExternalSearch>

> Links <javascript:PopUpMenu2_Set(Menu2699140);>

> *[significance of subjective symptoms and diagnostic criteria in

initial

> forms of cerebral circulation insufficiency]*

>

> [Article in Russian]

>

> *Eninia GI*<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

db=pubmed & cmd=Search & itool=pubmed_Abstract & term=%22Eninia+GI%22%

5BAuthor%5D>,

> *Purinia IV*<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

db=pubmed & cmd=Search & itool=pubmed_Abstract & term=%22Purinia+IV%22%

5BAuthor%5D>,

> *Robule VKh*<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

db=pubmed & cmd=Search & itool=pubmed_Abstract & term=%22Robule+VKh%22%

5BAuthor%5D>,

> *Maiore IKh*<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

db=pubmed & cmd=Search & itool=pubmed_Abstract & term=%22Maiore+IKh%22%

5BAuthor%5D>,

> *Timofeeva TN*<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

db=pubmed & cmd=Search & itool=pubmed_Abstract & term=%22Timofeeva+TN%22%

5BAuthor%5D>,

> *Berzina AIa*<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

db=pubmed & cmd=Search & itool=pubmed_Abstract & term=%22Berzina+AIa%22%

5BAuthor%5D>

> .

>

> Piracetam was applied to the treatment of 60 patients with initial

> manifestations of brain circulation failure and stage I circulatory

> encephalopathy. The drug exerted a beneficial therapeutic effect

by reducing

> high brain vascular resistance (both extra- and intracranial) and

by

> increasing the lowered volume of pulse fluctuations. It made

fibrinolytic

> blood activity and aggregation of formed elements of the blood

return to

> normal. An appreciable antiatherogenic effect was discovered as

well. It

> should be taken into consideration that in patients with a

dramatic lowering

> of pulse fluctuations, the use of piracetam in a dose of 1.6 g/day

may

> enhance headache. In such cases the dose should be reduced.

>

> Publication Types:

>

> - Comparative Study <javascript:AL_get

(this, 'ptyp', 'Comparative

> Study ');>

> - English Abstract <javascript:AL_get(this, 'ptyp', 'English

> Abstract');>

>

>

> PMID: 2699140 [PubMed - indexed for MEDLINE]Eur Neurol.

> 1978;17(1):50-5. Compound

> via MeSH,<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

itool=pubmed_AbstractPlus & db=pubmed & cmd=Display & dopt=pubmed_pccompoun

d_mesh & from_uid=342247>

> Substance

> via MeSH,<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

itool=pubmed_AbstractPlus & db=pubmed & cmd=Display & dopt=pubmed_pcsubstan

ce_mesh & from_uid=342247>

> LinkOut<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

itool=pubmed_AbstractPlus & cmd=Retrieve & db=pubmed & list_uids=342247 & dop

t=%20ExternalLink>

> Piracetam in the treatment of post-concussional syndrome. A double-

blind

> study.

>

> - *Hakkarainen

> H*<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

db=pubmed & cmd=Search & itool=pubmed_AbstractPlus & term=%22Hakkarainen+H%

22%5BAuthor%5D>,

>

> - *Hakamies L*<http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?

db=pubmed & cmd=Search & itool=pubmed_AbstractPlus & term=%22Hakamies+L%22%

5BAuthor%5D>

> .

>

> The effect of piracetam, a cyclical derivative of GABA, was

compared with

> that of a placebo in a double-blind study of 60 patients with

> post-concussional syndrome of 2-12 months' duration. The daily

dose of

> piracetam was 4,800 mg. After 8 weeks of treatment piracetam

significantly

> reduced the occurrence and severity of the following symptoms:

vertigo,

> headache, tiredness, decresed alertness, increased sweating and

neurasthenic

> symptoms. No significant effect was observed on the following

symptoms:

> tremor, orthostatic symptoms, and memory disorders. Side effect

were

> reported by 64% of the patients under piracetam and by 32% under

placebo. In

> the author's opinion, piracetam seems to be a promising new drug

for the

> treatment of post-concussional syndrome.

>

> PMID: 342247 [PubMed - indexed for MEDLINE]

>

>

>

[Guest guest]

Barb, when I first got ill I had chronic sinititus, and retinitis, (I

know they are not spelled right). but I had sinus surgery eventually

but unfortunately my landlords were painting and removing wallpaper

while I was awaiting surgery. They even wanted to replace windows the

week of my surgery. I called the attorney general's office and

everyone I could think of cuz it was making me sicker and of course it

was stachybotrus and it was too bad for me. I had surgery and had to

move in six weeks time. No help for the sick. But my sinuses are

better where I don't have the pain constantly just when exposed to

certain chemicals, and mold.

> >

> > KC when you talk about Sharon's head pain has she had cat scans of

> > the sinuses, etc. I have migranes many times but when I first got

> > ill I had such severe pain and had been on alot of meds and I >

>

[Guest guest]

exactually!just the other day I started to try to explain chronic

fatique to my mom to try to get her to understand how it keeps me

from getting things done and she said'oh, I had that for a couple of

weeks not to long ago' I just shut up, it's hopeless.

> > > >

> > > > KC (Jane & LiveSimply): In understanding the reason micro

> fungi

> > do what

> > > > they do, the simplest " on/off switch " reason is that they are

> > primary

> > > > " decomposers. " Decomposers are scavengers in that they will

> feed

> > on nearly

> > > > anything as their " prey " , including animals and humans. Micro

> > fungi are not

> > > > " plant life " and are far removed from plants physically,

> > genetically,

> > > > structureally, and in how they create and feed of the

> nutrients

> > that they

> > > > grow from. They are not mobile but stationary and this is why

> > they often are

> > > > mistaken for plant life. The very reason they are able to

> elude

> > the human

> > > > immune system is that they have a very similar appearance

with

> > our human

> > > > immune cells. I personally refer to our human immune system

as

> > our " human

> > > > fungal system " because as micro fungi cells are generated

from

> > basic

> > > > chemical structure so are the human immune cells. In

> addressing

> > their prey,

> > > > micro fungi cells are very similar to human immune system

> cells,

> > or vice

> > > > versa. In escaping detection within the human body by the

> immune

> > system

> > > > cells, they are able to deceive our immune cells in a process

> > called

> > > > " molecular mimicry. " This same process is why micro fungi are

> > extremely

> > > > difficult to detect in our blood serum as they take on the

> > appearance of

> > > > human blood cells cells in traveling through the human blood

> > stream to where

> > > > they need to go to do what they need to do. The micro fungi

> cell

> > appears

> > > > very much like a blood cell except for one critical fact;

they

> > are much

> > > > smaller than human blood cells. It is interesting to note,

> that

> > micro fungi

> > > > are closer to humans than their counterpart " primary

> decomposers "

> > bacteria.

> > > > In fact, fungi cells have a defined " nucleus " , whereas

> bacteria

> > do not have

> > > > a nucleus. The micro fungi are allowed by our molecular

system

> to

> > penetrate

> > > > further into the human body because the human immune cells

> > usually do not

> > > > recognize them as pathogens (disease causing) as some Gram-

> > Negative and

> > > > Gram-Positive bacteria are immediately recognized. Molds

> invade

> > very subtly

> > > > and absorb chemically as pathogens integrating with human

> cells

> > over

> > > > sometimes months and years to invade and mutate cells, as

> opposed

> > to

> > > > bacteria and viruses which are often immediately recognized

> > before they can

> > > > do harm. In this way micro fungi are able to adapt and

> eventually

> > gain

> > > > strength in numbers (or clusters) as " colonies. " When

symptoms

> > arise it

> > > > often signals to the human body cells that micro fungi are

> > decomposing or

> > > > attempting to decompose by first feeding off from what their

> > human host is

> > > > feeding on (i.e., sugars, starches, proteins, etc.) and then

> > instead of

> > > > being content, the micro fungi begin " opportunistically " to

> > release

> > > > mycotoxins (poisons) that continuously attack the human cell

> > genetic

> > > > structure. This begins in a process of friction, followed by

> > inflammation as

> > > > weakened human cell chemistry clashes and eventually gives

way

> to

> > mycotoxin

> > > > chemistry in challenging and changing DNA/RNA (genetic) amino

> > acid string

> > > > bases. This process leads to diseases because both human

> cells,

> > micro fungi

> > > > cells, bacterial cells, and other live organism cells that

> > compose the human

> > > > body also become ill along the way. This is a two-billion

year

> > old microbial

> > > > (live cell) war that has been going on internally called " the

> > Carbon Cycle "

> > > > or " dust-to-dust " Think about it, a person usually does not

> die

> > suddenly

> > > > naturally, but slowly over years (such as in cancers, MS,

> > Parkinson's, etc.)

> > > > in a decomposing process in which the organs begin to fail.

> > Normally it is

> > > > not one organ that fails but a cascade of failures before

> death.

> > However,

> > > > this process has a very fast nature to it as well, such as

> > observed with

> > > > Mucormycosis. It also is not often a challenge of one micro

> > fungal species

> > > > but several giving off many types of mycotoxins in the

> process,

> > unlike

> > > > bacteria that usually is an attack by one bacterial species.

> This

> > is why it

> > > > is extremely difficult to pinpoint " dose-response " in the

> > formation of

> > > > fungal exposures and the disease process.

> > > >

> > > > Hope this helps.

> > > >

> > > > God Bless you and your continuing progress toward improved

> health.

> > > >

> > > > Doug Haney

> > > > EnviroHealth Research & Consulting, Inc.

> > > > Email: _Haney52@ <_Haney52%40hotmail.com>

> > > >

> > > >

> > > >

> > > >

> > > >

> > >

> > >

> > >

[Guest guest]

That's what happens when I say I have insomnia which is very bad or

was at one time horrible. EVERYONE would agree with statement that

they hadn't slept enough, even people who got 7 instead of 8. I

stopped mentioning it for that reason. It was insulting because the

lack of sleep was keeping me from normal activities and for other

people to equate themselves with me was like saying, 'me too but I

don't let it bother me!!!'

>

> exactually!just the other day I started to try to explain chronic

> fatique to my mom to try to get her to understand how it keeps me

> from getting things done and she said'oh, I had that for a couple of

> weeks not to long ago' I just shut up, it's hopeless

[Guest guest]

-Yes, 0ver 10 years of growing debilitation from Migraine was stopped-

just by moving-now when I feel that stabbing pain start in my eye- I

know there is some mold around.

karen-- In , LiveSimply

<quackadillian@...> wrote:

>

> ,

>

> Have you tried PIRACETAM for your wife's headaches? Piracetam is a

> neuroprotective supplement that is affordable and which has 40

years of

> supporting evidence behind its use in neuroprotection.

>

>

> If you combine piracetam with choline and vitamin B5 it also

improves (long

> term) memory. This isn't just me talking, the science is there, 40

years of

> it.

>

> There is a list at

>

> http://www.he.net/~altonweb/cs/downsyndrome/index.htm?

page=piraceso.html

>

> of places where you can buy piracetam and considering the

incredible relief

> it brought me when I was getting those headaches I would strongly

urge you

> to check it out. Its cheap.

>

> But you ALSO need to consider the possibility that whatever is

making her

> have these headaches is NOT MOLD, it might be a brain tumor or

something

> like that. If you have not already, she needs to have a neurologist

look at

> the situation and she should get a brain scan to rule out possible

other

> causes.. This can be expensive but don't scrimp on this!

>

> if you have already done all this disregard this letter but I had

to write

> it because I went through this myself and it turned out to be

stachy... bad,

> toxic stachy.. and asp/pen...

>

> Headaches for most of us are not normal. For me, it is one of the

symptoms

> of mold exposure.. but not for everybody..sometimes it is cancer or

> pre-stroke or similar...

>

> Again, sorry to be repetitive/redundant if so..

>

>

>

[Guest guest]

Barb, for some, getting family to understand might be thier only

chance to get to a expert for proper medical help.

> >

> > exactually!just the other day I started to try to explain chronic

> > fatique to my mom to try to get her to understand how it keeps me

> > from getting things done and she said'oh, I had that for a couple

of

> > weeks not to long ago' I just shut up, it's hopeless

>

[Guest guest]

Well, the times I was off of this group in last year since my home

remediation I must have missed out on a lot and do want to read

Doug's book, Carl's, and Jeff's and will be looking to get these in

the future since I have been living the nightmare of what is in these

books. If you write another book, I could be a chapter in your books

as well as all us group members here. The living nightmare of

breathing mycotoxins and survival.... Rhonda

>> KC (Jane & LiveSimply): In

understanding the reason micro fungi do what they do, the

simplest " on/off switch " reason is that they are

primary " decomposers. " Decomposers are scavengers in that they will

feed on nearly anything as their " prey " , including animals and

humans. Micro fungi are not " plant life " and are far removed from

plants physically, genetically, structureally, and in how they create

and feed of the nutrients that they grow from. They are not mobile

but stationary and this is why they often are mistaken for plant

life. The very reason they are able to elude the human immune system

is that they have a very similar appearance with our human immune

cells. I personally refer to our human immune system as our " human

fungal system " because as micro fungi cells are generated from basic

chemical structure so are the human immune cells. In addressing their

prey, micro fungi cells are very similar to human immune system

cells, or vice versa. In escaping detection within the human body by

the immune system cells, they are able to deceive our immune cells in

a process called " molecular mimicry. " This same process is why micro

fungi are extremely difficult to detect in our blood serum as they

take on the appearance of human blood cells cells in traveling

through the human blood stream to where they need to go to do what

they need to do. The micro fungi cell appears very much like a blood

cell except for one critical fact; they are much smaller than human

blood cells. It is interesting to note, that micro fungi are closer

to humans than their counterpart " primary decomposers " bacteria. In

fact, fungi cells have a defined " nucleus " , whereas bacteria do not

have a nucleus. The micro fungi are allowed by our molecular system

to penetrate further into the human body because the human immune

cells usually do not recognize them as pathogens (disease causing) as

some Gram-Negative and Gram-Positive bacteria are immediately

recognized. Molds invade very subtly and absorb chemically as

pathogens integrating with human cells over sometimes months and

years to invade and mutate cells, as opposed to bacteria and viruses

which are often immediately recognized before they can do harm. In

this way micro fungi are able to adapt and eventually gain strength

in numbers (or clusters) as " colonies. " When symptoms arise it often

signals to the human body cells that micro fungi are decomposing or

attempting to decompose by first feeding off from what their human

host is feeding on (i.e., sugars, starches, proteins, etc.) and then

instead of being content, the micro fungi begin " opportunistically "

to release mycotoxins (poisons) that continuously attack the human

cell genetic structure. This begins in a process of friction,

followed by inflammation as weakened human cell chemistry clashes and

eventually gives way to mycotoxin chemistry in challenging and

changing DNA/RNA (genetic) amino acid string bases. This process

leads to diseases because both human cells, micro fungi cells,

bacterial cells, and other live organism cells that compose the human

body also become ill along the way. This is a two-billion year old

microbial (live cell) war that has been going on internally

called " the Carbon Cycle " or " dust-to-dust " Think about it, a person

usually does not die suddenly naturally, but slowly over years (such

as in cancers, MS, Parkinson's, etc.) in a decomposing process in

which the organs begin to fail. Normally it is not one organ that

fails but a cascade of failures before death. However, this process

has a very fast nature to it as well, such as observed with

Mucormycosis. It also is not often a challenge of one micro fungal

species but several giving off many types of mycotoxins in the

process, unlike bacteria that usually is an attack by one bacterial

species. This is why it is extremely difficult to pinpoint " dose-

response " in the formation of fungal exposures and the disease

process. > > Hope this helps. > > God Bless you and your continuing

progress toward improved health. > > Doug Haney> EnviroHealth

Research & Consulting, Inc.> Email: _Haney52@> > > > > > > > >

__________________________________________________________> Get the

Live.com Holiday Page for recipes, gift-giving ideas, and more.>

www.live.com/?addtemplate=holiday> > [Non-text portions of this

message have been removed]>

>

>

> _________________________________________________________________

> Try amazing new 3D maps

> http://maps.live.com/?wip=51

>

>